CY2007011I1 - Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους - Google Patents
Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τουςInfo
- Publication number
- CY2007011I1 CY2007011I1 CY2007011C CY2007011C CY2007011I1 CY 2007011 I1 CY2007011 I1 CY 2007011I1 CY 2007011 C CY2007011 C CY 2007011C CY 2007011 C CY2007011 C CY 2007011C CY 2007011 I1 CY2007011 I1 CY 2007011I1
- Authority
- CY
- Cyprus
- Prior art keywords
- azadicyclo
- polyforms
- octane
- amine
- pharmaceutical compositions
- Prior art date
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 title 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13699299P | 1999-06-01 | 1999-06-01 | |
PCT/IB2000/000665 WO2000073304A1 (en) | 1999-06-01 | 2000-05-18 | Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
CY2007011I1 true CY2007011I1 (el) | 2010-07-28 |
CY2007011I2 CY2007011I2 (el) | 2010-07-28 |
Family
ID=22475338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY2007011C CY2007011I2 (el) | 1999-06-01 | 2007-03-27 | Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους |
Country Status (49)
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2005216709B2 (en) * | 2004-01-30 | 2008-02-07 | Zoetis Services Llc | Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
AU2005216706B2 (en) * | 2004-01-30 | 2007-11-29 | Pfizer Products Inc. | NK-1 receptor antagonists anesthesia recovery |
CA2554908A1 (en) * | 2004-01-30 | 2005-09-09 | Pfizer Products Inc. | Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
US20090099364A1 (en) * | 2004-02-02 | 2009-04-16 | Pfizer Inc. | Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine |
CA2905542C (en) * | 2013-03-15 | 2022-05-03 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
CN110577522B (zh) * | 2018-06-07 | 2022-12-27 | 东莞市东阳光动物保健药品有限公司 | 马罗匹坦柠檬酸盐新晶型及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2084361T3 (es) * | 1991-05-31 | 1996-05-01 | Pfizer | Derivados de quinuclidina. |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
-
2000
- 2000-05-08 US US09/566,307 patent/US6255320B1/en not_active Expired - Lifetime
- 2000-05-17 HN HN2000000077A patent/HN2000000077A/es unknown
- 2000-05-18 PL PL00352716A patent/PL196046B1/pl not_active IP Right Cessation
- 2000-05-18 SK SK1733-2001A patent/SK285820B6/sk not_active IP Right Cessation
- 2000-05-18 DK DK00925528T patent/DK1181290T3/da active
- 2000-05-18 ES ES00925528T patent/ES2199825T3/es not_active Expired - Lifetime
- 2000-05-18 DE DE60003679T patent/DE60003679T2/de not_active Expired - Lifetime
- 2000-05-18 CA CA002372238A patent/CA2372238C/en not_active Expired - Lifetime
- 2000-05-18 CN CNB008082782A patent/CN1146565C/zh not_active Expired - Lifetime
- 2000-05-18 TR TR2001/03473T patent/TR200103473T2/xx unknown
- 2000-05-18 PT PT00925528T patent/PT1181290E/pt unknown
- 2000-05-18 KR KR10-2001-7015494A patent/KR100476606B1/ko not_active IP Right Cessation
- 2000-05-18 MX MXPA01012325A patent/MXPA01012325A/es unknown
- 2000-05-18 AU AU44248/00A patent/AU767334B2/en not_active Expired
- 2000-05-18 CZ CZ20014269A patent/CZ295819B6/cs not_active IP Right Cessation
- 2000-05-18 JP JP2001500629A patent/JP3830816B2/ja not_active Expired - Lifetime
- 2000-05-18 NZ NZ515349A patent/NZ515349A/xx unknown
- 2000-05-18 SI SI200030161T patent/SI1181290T1/xx unknown
- 2000-05-18 WO PCT/IB2000/000665 patent/WO2000073304A1/en active IP Right Grant
- 2000-05-18 AP APAP/P/2001/002349A patent/AP2001002349A0/en unknown
- 2000-05-18 BR BR0011094-9A patent/BR0011094A/pt not_active Application Discontinuation
- 2000-05-18 HU HU0201301A patent/HUP0201301A3/hu unknown
- 2000-05-18 UA UA2001118214A patent/UA66925C2/uk unknown
- 2000-05-18 EA EA200101108A patent/EA003731B1/ru active Protection Beyond IP Right Term
- 2000-05-18 EP EP00925528A patent/EP1181290B1/en not_active Expired - Lifetime
- 2000-05-18 IL IL14640600A patent/IL146406A0/xx not_active IP Right Cessation
- 2000-05-18 OA OA1200100318A patent/OA11956A/en unknown
- 2000-05-18 YU YU81101A patent/YU81101A/sh unknown
- 2000-05-18 EE EEP200100656A patent/EE200100656A/xx unknown
- 2000-05-18 AT AT00925528T patent/ATE244239T1/de not_active IP Right Cessation
- 2000-05-23 PA PA20008496101A patent/PA8496101A1/es unknown
- 2000-05-26 CO CO00039195A patent/CO5170463A1/es not_active Application Discontinuation
- 2000-05-26 TW TW089110206A patent/TWI285204B/zh not_active IP Right Cessation
- 2000-05-29 UY UY26176A patent/UY26176A1/es not_active Application Discontinuation
- 2000-05-30 MY MYPI20002409A patent/MY133508A/en unknown
- 2000-05-30 AR ARP000102663A patent/AR033331A1/es active IP Right Grant
- 2000-05-30 PE PE2000000520A patent/PE20010209A1/es not_active Application Discontinuation
- 2000-05-31 TN TNTNSN00120A patent/TNSN00120A1/fr unknown
- 2000-05-31 DZ DZ000101A patent/DZ3050A1/xx active
- 2000-05-31 GT GT200000087A patent/GT200000087A/es unknown
- 2000-05-31 MA MA25997A patent/MA26742A1/fr unknown
- 2000-05-31 SV SV2000000093A patent/SV2001000093A/es unknown
- 2000-06-01 EC EC2000003508A patent/ECSP003508A/es unknown
-
2001
- 2001-11-28 ZA ZA200109775A patent/ZA200109775B/en unknown
- 2001-11-30 NO NO20015848A patent/NO20015848L/no not_active Application Discontinuation
- 2001-12-04 HR HR20010904A patent/HRP20010904A2/hr not_active Application Discontinuation
- 2001-12-10 BG BG106204A patent/BG65240B1/bg unknown
-
2002
- 2002-10-30 HK HK02107879A patent/HK1046284A1/xx not_active IP Right Cessation
-
2007
- 2007-03-27 CY CY2007011C patent/CY2007011I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
MA27392A1 (fr) | Nouveaux derives d'aminoindazoles a titre de medicaments et compositions pharmaceutiques les renfermant | |
IT1313549B1 (it) | Formulazioni farmaceutiche a base di epotilone 3 | |
FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
MA26816A1 (fr) | Derives d'amino-triazolopyridine | |
DK1095932T3 (da) | Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme | |
FR2805818B1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
EE200100022A (et) | Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon | |
HUP0004050A3 (en) | Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same | |
NO992339L (no) | Farmasöytiske formuleringer | |
DE69822172D1 (de) | Levosimendanhaltige oral anzuwendende arzneizusammensetzungen | |
ITMI982222A0 (it) | Composizioni farmaceutiche orali contenenti buprenorfina | |
CY2007011I1 (el) | Πολυμορφες ενος κρυσταλλικου κιτρικου αλατος αζαδικυκλο (2,2,2) οκταν -3- αμινης και φαρμακευτικες συνθεσεις τους | |
HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
EE200200281A (et) | Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks | |
NO20020760L (no) | Farmasöytiske sammensetninger for oral og topisk administrasjon | |
FR2833842B1 (fr) | Compositions pharmaceutiques a base de derives d'azetidine | |
HUP0104549A3 (en) | Imidazo-pyridine sulfonamide derivatives and pharmaceutical compositions thereof | |
FR2796829B1 (fr) | Plaque d'osteotomie tibiale | |
FR2779145B1 (fr) | Nouvelles compositions pharmaceutiques | |
ITMI951417A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
IS6159A (is) | Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar | |
IT1289238B1 (it) | Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina | |
EE200000459A (et) | Farmatseutilised kompositsioonid |